By. Mohamed H. Derbala, MDDate. October 31, 2023 Mohamed H. Derbala, MD, an immuno-oncology expert and a Research Scientist at MD Anderson Cancer Center, is slated to share his expertise during an exclusive interview. The discussion will revolve around pivotal inquiries concerning TIGIT and its implications in immunotherapy. The interview will provide a comprehensive exploration … Continue reading Anti-TIGIT Therapy: Balancing Promise and Challenges in Unleashing Potential.